These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 25728078)

  • 1. Primary human cytomegalovirus infections: kinetics of ELISA-IgG and neutralizing antibody in pauci/asymptomatic pregnant women vs symptomatic non-pregnant subjects.
    Fornara C; Furione M; Lilleri D; Cane I; Revello MG; Zavattoni M; Gerna G
    J Clin Virol; 2015 Mar; 64():45-51. PubMed ID: 25728078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralizing and ELISA IgG antibodies to human cytomegalovirus glycoprotein complexes may help date the onset of primary infection in pregnancy.
    Lilleri D; Gerna G; Furione M; Zavattoni M; Spinillo A
    J Clin Virol; 2016 Aug; 81():16-24. PubMed ID: 27289427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal Antibodies to Different Components of the Human Cytomegalovirus (HCMV) Pentamer gH/gL/pUL128L and Trimer gH/gL/gO as well as Antibodies Elicited during Primary HCMV Infection Prevent Epithelial Cell Syncytium Formation.
    Gerna G; Percivalle E; Perez L; Lanzavecchia A; Lilleri D
    J Virol; 2016 Jul; 90(14):6216-6223. PubMed ID: 27122579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential kinetics of human cytomegalovirus load and antibody responses in primary infection of the immunocompetent and immunocompromised host.
    Gerna G; Lilleri D; Fornara C; Bruno F; Gabanti E; Cane I; Furione M; Revello MG
    J Gen Virol; 2015 Feb; 96(Pt 2):360-369. PubMed ID: 25316796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal human cytomegalovirus transmission correlates with delayed maternal antibodies to gH/gL/pUL128-130-131 complex during primary infection.
    Lilleri D; Kabanova A; Revello MG; Percivalle E; Sarasini A; Genini E; Sallusto F; Lanzavecchia A; Corti D; Gerna G
    PLoS One; 2013; 8(3):e59863. PubMed ID: 23555812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum antibody response to the gH/gL/pUL128-131 five-protein complex of human cytomegalovirus (HCMV) in primary and reactivated HCMV infections.
    Genini E; Percivalle E; Sarasini A; Revello MG; Baldanti F; Gerna G
    J Clin Virol; 2011 Oct; 52(2):113-8. PubMed ID: 21820353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human cytomegalovirus (HCMV)-specific T cell but not neutralizing or IgG binding antibody responses to glycoprotein complexes gB, gHgLgO, and pUL128L correlate with protection against high HCMV viral load reactivation in solid-organ transplant recipients.
    Lilleri D; Zelini P; Fornara C; Zavaglio F; Rampino T; Perez L; Gabanti E; Gerna G
    J Med Virol; 2018 Oct; 90(10):1620-1628. PubMed ID: 29797330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RT-qPCR-based microneutralization assay for human cytomegalovirus using fibroblasts and epithelial cells.
    Wang X; Peden K; Murata H
    Vaccine; 2015 Dec; 33(51):7254-7261. PubMed ID: 26552003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of recombinant glycoprotein antigens gB and gH for diagnosis of primary human cytomegalovirus infection during pregnancy.
    Eggers M; Radsak K; Enders G; Reschke M
    J Med Virol; 2001 Feb; 63(2):135-42. PubMed ID: 11170050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Slow increase in IgG avidity correlates with prevention of human cytomegalovirus transmission to the fetus.
    Furione M; Rognoni V; Sarasini A; Zavattoni M; Lilleri D; Gerna G; Revello MG
    J Med Virol; 2013 Nov; 85(11):1960-7. PubMed ID: 23893782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cytomegalovirus tropism for endothelial/epithelial cells: scientific background and clinical implications.
    Revello MG; Gerna G
    Rev Med Virol; 2010 May; 20(3):136-55. PubMed ID: 20084641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follicular helper T-cells and virus-specific antibody response in primary and reactivated human cytomegalovirus infections of the immunocompetent and immunocompromised transplant patients.
    Bruno F; Fornara C; Zelini P; Furione M; Carrara E; Scaramuzzi L; Cane I; Mele F; Sallusto F; Lilleri D; Gerna G
    J Gen Virol; 2016 Aug; 97(8):1928-1941. PubMed ID: 27113912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of Genotype-Specific Antibody Responses to Glycoproteins B and H in Primary and Non-Primary Human Cytomegalovirus Infections by Peptide-Based ELISA.
    Zavaglio F; Fiorina L; Suárez NM; Fornara C; De Cicco M; Cirasola D; Davison AJ; Gerna G; Lilleri D
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33802390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of anti-p52 IgM and anti-gB IgG by ELISA as a novel diagnostic tool for detection of early and late phase of primary human cytomegalovirus infections during pregnancy.
    Zelini P; Fornara C; Furione M; Sarasini A; Klemens J; Arossa A; Spinillo A; Gerna G; Lilleri D
    J Clin Virol; 2019 Nov; 120():38-43. PubMed ID: 31546089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vectored co-delivery of human cytomegalovirus gH and gL proteins elicits potent complement-independent neutralizing antibodies.
    Loomis RJ; Lilja AE; Monroe J; Balabanis KA; Brito LA; Palladino G; Franti M; Mandl CW; Barnett SW; Mason PW
    Vaccine; 2013 Jan; 31(6):919-26. PubMed ID: 23246547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limited Effector Memory B-Cell Response to Envelope Glycoprotein B During Primary Human Cytomegalovirus Infection.
    Dauby N; Sartori D; Kummert C; Lecomte S; Haelterman E; Delforge ML; Donner C; Mach M; Marchant A
    J Infect Dis; 2016 May; 213(10):1642-50. PubMed ID: 26715677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies against neutralization epitopes of human cytomegalovirus gH/gL/pUL128-130-131 complex and virus spreading may correlate with virus control in vivo.
    Lilleri D; Kabanova A; Lanzavecchia A; Gerna G
    J Clin Immunol; 2012 Dec; 32(6):1324-31. PubMed ID: 22836657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. False human cytomegalovirus IgG-positivity at prenatal screening.
    Furione M; Sarasini A; Arossa A; Fornara C; Lilleri D; Perez L; Parea M; Zavattoni M; Spinillo A; Marone P; Baldanti F
    J Clin Virol; 2018 Jul; 104():34-38. PubMed ID: 29705613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of association between the kinetics of human cytomegalovirus (HCMV) glycoprotein B (gB)-specific and neutralizing serum antibodies and development or recovery from HCMV active infection in patients undergoing allogeneic stem cell transplant.
    Muñoz I; Gutiérrez A; Gimeno C; Farga A; Alberola J; Solano C; Prósper F; García-Conde J; Navarro D
    J Med Virol; 2001 Sep; 65(1):77-84. PubMed ID: 11505447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of human cytomegalovirus (HCMV) neutralizing antibodies with antibodies to the HCMV glycoprotein complexes.
    Shibamura M; Yoshikawa T; Yamada S; Inagaki T; Nguyen PHA; Fujii H; Harada S; Fukushi S; Oka A; Mizuguchi M; Saijo M
    Virol J; 2020 Aug; 17(1):120. PubMed ID: 32746933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.